# EXACT SCIENCES CORP · Edgar & Edgarette company card

> Exact Sciences grew revenue 17.7% in FY2025 to $3.2 billion, operating margin -6.4% against a -12.4% median for medical laboratories, equity 41.0% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1124140 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/1124140) · [JSON](https://www.pops4.com/boards/company/1124140.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $3.2B |
| Revenue growth, 1 year | 17.7% |
| Revenue growth per year | 16.4% |
| Operating margin | -6.4% (prior year -38.0%) |
| Net margin | -6.4% |
| Operating cash flow | $491M |
| Capital spending | $135M |
| Free cash flow | $357M |
| Cash | $956M |
| Long-term debt | — |
| Total assets | $5.9B |
| Total equity | $2.4B |
| Equity ÷ assets | 41.0% |
| Return on equity | -8.7% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -1.1 (distress zone)
- Piotroski F: 7 of 9 (solid)
- Beneish M: -2.83 (below the −1.78 line)
- Health Harbor boat: Sound ship · one warning sign · operating loss: a margin of -6.4% in FY2025
- Cash Compass: Cash cow later · growing fast, and already turning revenue into cash

## Edgarette's reading

Exposure: revenue $3.2B (FY2025). Experience: revenue up 17.7% on the year, up 16.4% a year over 4 years; operating margin -6.4%, up from -38.0%. Soundness: equity 41.0% of assets, return on equity -8.7%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $3.4B and $4.1B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $3.2B to $4.3B. A statistical range, not company guidance. Against peers (17 filers, $50M+ revenue, services-medical laboratories): operating margin -6.4% against a -12.4% median; growth 17.7% against 13.8%.

Range logged 2026-10-31, receipt 590fbfae71ee99ec, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-03-23 ([filing](https://www.sec.gov/Archives/edgar/data/1124140/000119312526118700/0001193125-26-118700-index.htm))
- Item 5.02 Director or officer change: 2, latest 2026-03-23 ([filing](https://www.sec.gov/Archives/edgar/data/1124140/000119312526118700/0001193125-26-118700-index.htm))

## Recent filings

- 8-K · filed 2026-03-23 · 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.01 Notice of Delisting or Failure to Satisfy a Listing Rule; 3.03 Material Modifications to Rights of Security Holders; 5.01 Changes in Control of Registrant; 5.02 Departure or Election of Directors; Appointment of Officers; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1124140/000119312526118700/0001193125-26-118700-index.htm)
- 8-K · filed 2026-03-20 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1124140/000119312526116862/0001193125-26-116862-index.htm)
- 8-K · filed 2026-02-20 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1124140/000119312526061570/0001193125-26-061570-index.htm)
- 10-K · filed 2026-02-13 · [filing](https://www.sec.gov/Archives/edgar/data/1124140/000112414026000011/0001124140-26-000011-index.htm)
- 8-K · filed 2026-02-13 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1124140/000112414026000010/0001124140-26-000010-index.htm)
- 8-K · filed 2026-02-10 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1124140/000119312526044657/0001193125-26-044657-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001124140.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1124140

## Cite

POPS4, Edgar & Edgarette: EXACT SCIENCES CORP company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/1124140. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.